Collecting urine to test a new bladder cancer detection method
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study collects urine samples to test UroAmp, a new genetic test that may help detect and monitor bladder cancer. It is for people with bladder cancer or blood in urine who want to help improve cancer detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You can provide at least 20cc (about 4 teaspoons) of urine
- If you have bladder cancer, you may be scheduled for a biopsy, surgery, or chemotherapy
- If you have blood in urine, you must have no history of bladder, kidney, or prostate cancer
- You cannot have a current urinary tract infection at the time of urine collection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a new lab test on urine can help sort out which people with small amounts of blood in the urine (microscopic hematuria) might have bladder cancer. It may help doctors evaluate symptoms more accurately and decide who needs further testing.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
This study looks at urothelial cancer (often bladder cancer) samples taken during diagnosis or standard treatment. It may help researchers better understand the disease by using tissue that doctors already need to collect for care.
This study tests whether a simple urine test can accurately identify cancer in the bladder, ureters (tubes between kidneys and bladder), or renal pelvis (part of the kidney). You would provide urine samples before your planned surgery, and researchers will compare the urine test results to your actual tissue diagnosis after surgery.
This study collects tissue and blood samples from people diagnosed with early-stage bladder cancer (tumors that have not invaded the bladder muscle). The goal is to use these samples for research that could improve future diagnosis and treatment. It may be an opportunity to contribute to medical research.
This trial collects clinical samples from adults who have suspected or confirmed urothelial (bladder/urinary tract lining) cancer. It helps researchers study the disease and may support future improvements in diagnosis or treatment.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.